Xiaoke Sun

412 total citations
28 papers, 262 citations indexed

About

Xiaoke Sun is a scholar working on Cancer Research, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xiaoke Sun has authored 28 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 13 papers in Molecular Biology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xiaoke Sun's work include Cancer-related molecular mechanisms research (10 papers), Lipid metabolism and disorders (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Xiaoke Sun is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Lipid metabolism and disorders (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Xiaoke Sun collaborates with scholars based in China, Hong Kong and Sweden. Xiaoke Sun's co-authors include Zhen Yang, Feng Wang, Tiejun Wu, Weihua Zhang, Hongliang Liu, Wen Meng, Xian Zhang, Yu Zhang, Yang Liu and Mingyu Zhang and has published in prestigious journals such as Chemical Engineering Journal, Frontiers in Immunology and Advanced Science.

In The Last Decade

Xiaoke Sun

26 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoke Sun China 10 137 108 45 45 44 28 262
Kunsheng Li China 10 180 1.3× 131 1.2× 25 0.6× 15 0.3× 55 1.3× 22 310
Azariyas A. Challa United States 7 128 0.9× 46 0.4× 63 1.4× 26 0.6× 27 0.6× 10 315
Daikun He China 12 181 1.3× 80 0.7× 125 2.8× 33 0.7× 47 1.1× 36 354
Zhanxiong Xue China 13 138 1.0× 60 0.6× 36 0.8× 71 1.6× 32 0.7× 20 336
Toshimi Imai Japan 9 134 1.0× 55 0.5× 70 1.6× 26 0.6× 113 2.6× 30 340
Zheyue Shu China 11 154 1.1× 103 1.0× 40 0.9× 61 1.4× 18 0.4× 23 337
Li Shi China 11 82 0.6× 39 0.4× 42 0.9× 42 0.9× 39 0.9× 26 307
Aradhana Mohan United States 8 331 2.4× 152 1.4× 69 1.5× 20 0.4× 33 0.8× 11 428
Yingwei Zhu China 11 129 0.9× 67 0.6× 53 1.2× 48 1.1× 33 0.8× 30 302
Amit Manhas United States 10 92 0.7× 27 0.3× 40 0.9× 19 0.4× 90 2.0× 33 261

Countries citing papers authored by Xiaoke Sun

Since Specialization
Citations

This map shows the geographic impact of Xiaoke Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoke Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoke Sun more than expected).

Fields of papers citing papers by Xiaoke Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoke Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoke Sun. The network helps show where Xiaoke Sun may publish in the future.

Co-authorship network of co-authors of Xiaoke Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoke Sun. A scholar is included among the top collaborators of Xiaoke Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoke Sun. Xiaoke Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jia, Tao, et al.. (2025). Modulating the metal–support interaction of Pt/CeO2 catalysts for enhanced chemodynamic therapy for lung cancer thearanostics. Chemical Engineering Journal. 520. 166044–166044. 1 indexed citations
2.
Li, Yan, et al.. (2025). Role of multi‑omics in advancing the understanding and treatment of prostate cancer (Review). Molecular Medicine Reports. 31(5). 1–17. 4 indexed citations
3.
4.
Chen, Han, Xiaoke Sun, Lin Li, et al.. (2025). Zebrafish xenografts in breast cancer research. Frontiers in Immunology. 16. 1540610–1540610. 1 indexed citations
5.
Sun, Xiaoke, et al.. (2024). Circulating levels of cytokines and risk of urologic cancers: a two-sample Mendelian randomization study. BMC Cancer. 24(1). 1261–1261. 1 indexed citations
6.
Bai, Yun, et al.. (2024). ANGPTL4 Stabilizes Bone Morphogenetic Protein 7 Through Deubiquitination and Promotes HCC Proliferation via the SMAD/MAPK Pathway. DNA and Cell Biology. 43(8). 395–400. 2 indexed citations
7.
8.
Bai, Yun, et al.. (2024). Effect of Deletion of ANGPTL4 Gene on Viability, Migration and Invasion Ability and Apoptosis of Hepatocellular Carcinoma Cells. Discovery Medicine. 36(180). 173–173. 6 indexed citations
9.
Liu, Wei, Xiaoke Sun, Yun Bai, et al.. (2024). RNA-seq shows Angiopoietin-like 4 promotes hepatocellular carcinoma progression by inducing M2 polarization of tumor-associated macrophages. International Journal of Biological Macromolecules. 287. 138523–138523.
10.
Sun, Xiaoke, et al.. (2023). A preliminary evaluation of targeted nanopore sequencing technology for the detection of Mycobacterium tuberculosis in bronchoalveolar lavage fluid specimens. Frontiers in Cellular and Infection Microbiology. 13. 1107990–1107990. 10 indexed citations
11.
Li, Yan, et al.. (2023). Application of targeted diagnosis of PSMA in the modality shift of prostate cancer diagnosis: a review. Frontiers in Oncology. 13. 1179595–1179595. 1 indexed citations
12.
Sun, Xiaoke, et al.. (2023). Construction and validation of a cuproptosis-related lncRNA prognosis signature in bladder carcinoma. Journal of Cancer Research and Clinical Oncology. 149(13). 11207–11221. 1 indexed citations
13.
Bai, Yun, Di Qu, Dan Lu, et al.. (2022). Pan‐cancer landscape of abnormal ctDNA methylation across human tumors. Cancer Genetics. 268-269. 37–45. 1 indexed citations
14.
15.
Sandeep, Bhushan, et al.. (2019). Etiology of right ventricular restrictive physiology early after repair of tetralogy of Fallot in pediatric patients. Journal of Cardiothoracic Surgery. 14(1). 84–84. 20 indexed citations
16.
17.
Sun, Xiaoke, et al.. (2017). Oroxyloside inhibits human glioma progression by suppressing proliferation, metastasis and inducing apoptosis related pathways. Biomedicine & Pharmacotherapy. 97. 1564–1574. 13 indexed citations
18.
Sun, Xiaoke, et al.. (2017). Linarin sensitizes tumor necrosis factor-related apoptosis (TRAIL)-induced ligand-triggered apoptosis in human glioma cells and in xenograft nude mice. Biomedicine & Pharmacotherapy. 95. 1607–1618. 17 indexed citations
19.
Yang, Zhen, Yu Zhang, Xian Zhang, et al.. (2015). Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma. Biomedicine & Pharmacotherapy. 75. 153–158. 44 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kunsheng Li Breakdown of academic impact, for papers by Azariyas A. Challa Breakdown of academic impact, for papers by Daikun He Breakdown of academic impact, for papers by Zhanxiong Xue Breakdown of academic impact, for papers by Toshimi Imai Breakdown of academic impact, for papers by Zheyue Shu Breakdown of academic impact, for papers by Li Shi Breakdown of academic impact, for papers by Aradhana Mohan Breakdown of academic impact, for papers by Yingwei Zhu Breakdown of academic impact, for papers by Amit Manhas
Rankless by CCL
2026